Concepedia

Juan Carlos López-Talavera

JC

29

Publications

3.8K

Citations

27

H-Index

1990

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Vall d'Hebron Hospital Universitari

University of Pittsburgh

Bristol-Myers Squibb (Germany)

Yale University

Juan Carlos López-Talavera is an author at Bristol-Myers Squibb (United States) specializing in medicine, hepatology, and liver physiology.

Top concepts

Publications per year

1990–2022

29

Publications

29

Evaluation of Antibodies to Hepatitis C Virus in a Study of Transfusion-Associated Hepatitis

Juan Ignacio Esteban, Antonio González, José M. Hernández et al. · New England Journal of Medicine · 1990 · 387 citations · Full text

High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus

Juan Carlos López-Talavera, P Madoz, L Viladomiu et al. · Annals of Internal Medicine · 1991 · 281 citations

Peginterferon alfa‐2a for hepatitis C after liver transplantation

Naga Chalasani, Cosme Manzarbeitia, Peter Ferenci et al. · Hepatology · 2005 · 277 citations · Full text

Phase 1b Study of Pegylated Interferon Lambda 1 With or Without Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection†

Andrew J. Muir, Mitchell L. Shiffman, Atif Zaman et al. · Hepatology · 2010 · 246 citations · Full text

Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.

Jordi Codony‐Servat, Joan Albanell, Juan Carlos López-Talavera et al. · PubMed · 1999 · 238 citations

, , +18

Rows per page

1–5 of 29